Quick Takeaways
- Robin L. Smith has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $247,415.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Robin L. Smith
- Location
- Melville, NY
- Summary
- The estimated net worth of Robin L. Smith is at least $247,415 dollars as of 02 May 2025. Robin L. Smith is the Director of Sorrento Therapeutics, Inc. and owns shares of Sorrento Therapeutics, Inc. (SRNE) stock worth about $188.6K. Robin L. Smith is the Director of Celularity Inc and owns shares of Celularity Inc (CELU) stock worth about $58.8K.
- Signature
- /s/ Keith A. Kucinski, attorney-in fact for Robin Smith
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robin L. Smith and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Sorrento Therapeutics, Inc. ($188,635).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Robin L. Smith
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SRNE | Sorrento Therapeutics, Inc. | Director | $188,635 | 03 Sep 2021 | ||
| CELU, CELUW | Celularity Inc | Director | $58,780 | 14 Jun 2023 | ||
| MTNB | Matinas BioPharma Holdings, Inc. | Director | 30 Apr 2025 | |||
| CYCU, CYCUW | Western Acquisition Ventures Corp. | Director | 11 Jan 2022 |
Insider Transactions Reported by Robin L. Smith:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.